---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Anti-infective Guidelines"
developer_entity: "MUMS Health"
bundle_id: "com.mumshealth.antiinfective"
app_store_id: "992143323"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: true
market_region: "US"
platforms: "iOS"
app_last_updated: "2019-09-12"
report_date: "2026-11-10"
last_verified: "2026-11-10T00:00:00.000Z"
report_version: "1.1"
total_reviews: 0
confidence: "medium"
confidence_score: 0.45
data_age_days: 4
momentum_velocity: "zombie"
intelligence_version: 7
nemesis: "MDCalc Medical Calculator"
competitor_count: 13
tags: ["medical", "paid", "mobile app", "app review", "app analysis", "family", "medicine", "practitioners"]
canonical_url: "https://marlvel.ai/apps/com-mumshealth-antiinfective"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Anti-infective Guidelines Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Paid

> **TL;DR:** Anti-infective Guidelines is a medical app by MUMS Health, available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Anti-infective Guidelines is a medical app by MUMS Health.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Category** | Medical |
| **Developer** | MUMS Health |
| **Pricing** | Paid |
| **Platforms** | iOS |
| **Confidence** | Medium (0.45/1.0) |
| **Data Age** | 4d |

## Metadata & Market Performance
- **Publisher:** MUMS Health
- **Category:** Medical
- **Target Audience:** Family medicine practitioners and emergency room staff requiring evidence-based, offline-accessible antibiotic guidelines.
- **Platforms:** iOS
- **Version Reviewed:** 1.1
- **Report Date:** 2026-11-10
- **Signal Count:** 38 reviews analyzed
- **Confidence:** Medium (0.45/1.0)
- **App Store ID (iOS):** 992143323
- **Bundle ID:** com.mumshealth.antiinfective
- **Performance Trend:** Stable
- **Data Window:** Analysis based on signals collected up to 2026-11-10

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Anti-infective Guidelines is a paid, offline-first antibiotic prescribing reference for family medicine and emergency room practitioners.
**Why users hire it:** It removes the dependency on internet connectivity for clinical decision support in hospital environments where network access is often unreliable.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Clinical Decision Tools:** Interactive logic flows for antibiotic prescription guidance; justifies the $17.99 price point.
- **[Standard] Offline Access:** Full content availability without internet; ensures reliability in hospital settings with poor connectivity.
  * *User Intent:* Users want uninterrupted access without internet dependency.
- **[Differentiator] Print Material Discount:** Access to discounted physical viral info pads via the website; cross-sells physical products to increase customer lifetime value.
  * *User Intent:* Users value self-expression and personalized experiences.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Anti-infective Guidelines holds a niche position in the Medical category, relying on a one-time $17.99 purchase. Its lack of updates since 2019 leaves it vulnerable to rivals like Johns Hopkins Antibiotic Guide that provide monthly content updates.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** One-time purchase at $17.99
- **Price:** iOS: $17.99
- **Analysis:** Paid model at $17.99 per download, with proceeds explicitly allocated to maintaining editorial independence.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Offline-first architecture ensures utility in hospital environments with poor connectivity

**Growth Levers:**
- Cross-selling physical viral info pads via the website provides a secondary revenue stream


<!-- /section:swot -->
## Recent Changes (v6 → v7) {#recent-changes}

The intelligence report now benchmarks the app against specific clinical competitors and formalizes the clinical relevance gap in the SWOT analysis. While the product remains in a static state, the competitive positioning has been sharpened to highlight the trade-offs between static, offline-first tools and dynamic, cloud-connected alternatives.

**Overall trend**: Stable
**Compared at**: 2026-11-10

### Medium-impact changes
- **[Shifted] Competitive Benchmarking in SWOT** (swot)
- **[Added] Formalized Feature Gaps** (features)

### Low-impact changes
- **[] Contrarian Take Refinement** (positioning)

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### Anti-infective Guidelines vs MDCalc Medical Calculator
- **[MDCalc Medical Calculator](https://marlvel.ai/apps/mdcalc-medical-calculator-1)**: Both apps target healthcare professionals requiring bedside clinical decision support, with both providing offline-first functionality for hospital environments with poor connectivity.
  - **Key differences:**
    - MDCalc provides a library of 900+ clinical calculators, while Anti-infective Guidelines focuses on a static antibiotic reference.
    - MDCalc includes CME tracking for professional development, a feature not present in Anti-infective Guidelines.
    - MDCalc utilizes a free, ad-supported model, whereas Anti-infective Guidelines requires a $17.99 one-time purchase.

### Contenders (Strong Challengers)
- **[5 Minute Clinical Consult 5MCC](https://marlvel.ai/apps/5-minute-clinical-consult-5mcc)**: Both apps target family medicine and emergency room practitioners with offline-capable clinical decision support, creating direct competition for the same professional user base.
  - 5MCC provides interactive clinical algorithms for decision support, whereas Anti-infective Guidelines relies on static, book-based content.
  - 5MCC includes personalized annotation tools that increase user switching costs, a feature absent in Anti-infective Guidelines.
- **[EMRA Antibiotic Guide](https://marlvel.ai/apps/com-emra-antibioticguide)**: Both apps target clinicians requiring antibiotic prescribing guidance, creating direct competition for the same professional user base in hospital environments.
  - EMRA includes a dosage calculator for clinical math; Anti-infective Guidelines lacks this specific utility.
  - EMRA utilizes a $9.99 annual subscription model; Anti-infective Guidelines requires a $17.99 one-time purchase.
- **[Pneumonia Guide](https://marlvel.ai/apps/pneumonia-guide)**: Both apps target clinicians requiring antibiotic and pneumonia management protocols, creating a direct conflict for the same professional user base. The rival provides a free, specialized alternative to the paid, static reference model of Anti-infective Guidelines.
  - Pneumonia Guide provides free access to current clinical guidelines, while Anti-infective Guidelines charges $17.99 for static content.
  - Pneumonia Guide includes pediatric-specific pneumonia protocols, a feature not present in the Anti-infective Guidelines feature set.
- **[Johns Hopkins Antibiotic Guide](https://marlvel.ai/apps/com-unboundmedicine-johnshopkinspocitguides)**: Both apps target clinicians requiring antibiotic decision support at the point of care, creating direct competition for the same professional user base.
  - Johns Hopkins provides monthly content updates, whereas Anti-infective Guidelines has remained static since 2019.
  - Johns Hopkins includes specialized psychedelic medicine guidance, a feature absent in Anti-infective Guidelines.
- **[Quick Diagnosis & Treatment](https://marlvel.ai/apps/com-mobisystems-mcgrawhillcmdtquickanswers2014)**: Both apps target medical professionals with paid, portable clinical references, creating direct competition for the same professional user base in hospital and office settings.
  - QMDT includes camera-based search to reduce time-to-information, while Anti-infective Guidelines relies on manual navigation.
  - QMDT utilizes CMDT content for clinical credibility, whereas Anti-infective Guidelines functions as a digital extension of the Orange Book.
- **[Concise Medicine Handbook](https://marlvel.ai/apps/com-rermedapps-concisemedicinepro)**: Both apps target medical professionals with clinical reference tools, creating direct competition for the limited attention of clinicians needing quick decision support.
  - Concise Medicine Handbook covers 950+ diseases across 12 specialties, whereas Anti-infective Guidelines focuses exclusively on antibiotic prescription.
  - Concise Medicine Handbook operates on a free model, contrasting with the $17.99 one-time purchase price of Anti-infective Guidelines.
- **[MobilEM](https://marlvel.ai/apps/com-emra-mobilem)**: Both apps target clinical professionals requiring evidence-based medical references, creating direct competition for the same professional's limited device storage and attention.
  - MobilEM includes note-taking and bookmarking tools that tether user-generated clinical data to the app.
  - MobilEM employs a freemium model with a la carte purchases, while Anti-infective Guidelines mandates a flat upfront payment.
- **[CDC Vaccine Schedules](https://marlvel.ai/apps/gov-cdc-ncird-vaccinesschedule)**: Both apps target healthcare professionals requiring clinical decision support tools for patient care, creating direct competition for space on a practitioner's device.
  - CDC Vaccine Schedules provides automatic content updates, whereas Anti-infective Guidelines relies on static data from 2019.
  - CDC Vaccine Schedules is free to download, while Anti-infective Guidelines requires a $17.99 one-time purchase.

### Peers (What They Do Better)
- **[Full Code Medical Simulation](https://marlvel.ai/apps/full-code-medical-simulation)**: This app targets the same medical professional audience but shifts the focus from static reference material to active clinical simulation and accredited education.
  - Library of over 200 peer-reviewed clinical cases
  - AI-driven patient conversations for assessment practice
- **[Eolas Medical](https://marlvel.ai/apps/eolas-medical)**: It acts as a centralized knowledge repository for clinical departments, contrasting with the standalone, static nature of Anti-infective Guidelines.
  - Centralized departmental knowledge hub for internal protocols
  - AI answer engine for specific institutional decision support
- **[ASRA Coags](https://marlvel.ai/apps/asra-coags)**: Both apps provide clinical decision support for specific medical guidelines, though this app focuses on anesthesia and pain procedures.
  - Society-sanctioned clinical standards for regional anesthesia
  - Procedure-based search to reduce clinical decision-making time
- **[Clinical Cases in Medicine](https://marlvel.ai/apps/com-rermedapps-medicinecases)**: This app serves the same medical student and practitioner demographic but focuses on examination preparation rather than clinical decision support.
  - Library of over 65 medical cases for OSCE preparation
  - System-specific examination guides for cardiovascular and respiratory systems

<!-- /section:rivals -->
<!-- section:whats-new -->
## What's New

- **Latest (v1.0.1, 8 years ago):** Addressed minor bugs.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- No major updates since 2019.
- Maintenance-mode development status.

> **Cadence:** 4 total versions · 0 majors in last 6 months · 78 days since last update · 1011 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Anti-infective Guidelines is a medical app that is a paid app.

<!-- speakable-start -->
> **Bottom Line:** Anti-infective Guidelines provides a reliable, offline-first reference, but the lack of updates since 2019 limits its clinical utility against rivals that provide current, evidence-based protocols.
<!-- speakable-end -->

**Best for:** Family medicine practitioners and emergency room staff requiring evidence-based, offline-accessible antibiotic guidelines.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [PIVOT] Pivot to a subscription model because the current static content model fails to fund necessary clinical updates → increase content relevance
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors


- Real-time clinical guideline updates (available in Johns Hopkins Antibiotic Guide but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Declining

The medical reference market is consolidating around dynamic, evidence-based tools that provide real-time updates. Anti-infective Guidelines remains exposed due to its static content model, which will likely lead to further decline in user trust and market share.

- 🔴 The lack of updates since 2019 creates a widening clinical relevance gap, which will accelerate user churn toward dynamic, updated competitors.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Confidence | Medium |
| Pricing Model | Paid |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Trend | Stable |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Anti-infective Guidelines** (this app) | N/A/5 | N/A | MUMS Health |
| [Quick Diagnosis & Treatment](https://marlvel.ai/apps/com-mobisystems-mcgrawhillcmdtquickanswers2014) | 4.7/5 | Excited | MobiSystems, Inc. |
| [Johns Hopkins Antibiotic Guide](https://marlvel.ai/apps/com-unboundmedicine-johnshopkinspocitguides) | 4.9/5 | Mixed | Unbound Medicine, Inc. |
| [MobilEM](https://marlvel.ai/apps/com-emra-mobilem) | 3.6/5 | n/a | Emergency Medicine Residents' Association |
| [CDC Vaccine Schedules](https://marlvel.ai/apps/gov-cdc-ncird-vaccinesschedule) | 3.5/5 | N/A | Centers For Disease Control and Prevention |
| [EMRA Antibiotic Guide](https://marlvel.ai/apps/com-emra-antibioticguide) | 3.3/5 | n/a | Emergency Medicine Residents' Association |

## Company Profile
- **Developer:** MUMS Health
- **Website:** [https://mumshealth.com](https://mumshealth.com)

## Data Sources & Links
- **App Store ID:** 992143323
- **Dev Site:** [Official Website](https://mumshealth.com)
- **Sources:** Developer website content, About us / company information, App store metadata.

## Related Intel Reports
- [*Quick Diagnosis & Treatment*](https://marlvel.ai/apps/com-mobisystems-mcgrawhillcmdtquickanswers2014) (MobiSystems, Inc.) · 4.7/5 Rating | Positive Sentiment
- [*Johns Hopkins Antibiotic Guide*](https://marlvel.ai/apps/com-unboundmedicine-johnshopkinspocitguides) (Unbound Medicine, Inc.) · 4.9/5 Rating
- [*MobilEM*](https://marlvel.ai/apps/com-emra-mobilem) (Emergency Medicine Residents' Association) · 3.6/5 Rating
- [*CDC Vaccine Schedules*](https://marlvel.ai/apps/gov-cdc-ncird-vaccinesschedule) (Centers For Disease Control and Prevention) · 3.5/5 Rating
- [*EMRA Antibiotic Guide*](https://marlvel.ai/apps/com-emra-antibioticguide) (Emergency Medicine Residents' Association) · 3.3/5 Rating
- [*Clinical Cases in Medicine*](https://marlvel.ai/apps/com-rermedapps-medicinecases) (RER MedApps) · 3.0/5 Rating
- [*Concise Medicine Handbook*](https://marlvel.ai/apps/com-rermedapps-concisemedicinepro) (RER MedApps) · N/A Rating
- [*5 Minute Clinical Consult 5MCC*](https://marlvel.ai/apps/5-minute-clinical-consult-5mcc) (Skyscape Medpresso Inc) · 4.6/5 Rating
- [*ASRA Coags*](https://marlvel.ai/apps/asra-coags) (American Society of Regional Anesthesia and Pain Medicine) · 1.3/5 Rating
- [*Pneumonia Guide*](https://marlvel.ai/apps/pneumonia-guide) (Joshua D. steinberg) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.45/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 38
- **Data Sources:** developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 4 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-mumshealth-antiinfective)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.